Skip to content
Aperlena
Free alerts

España - Hipotensores - Suministro de medicamentos de uso humano que contiene los principios activos Romiplostim, Carfilzomib y Etelcalcetida, con destino a los centros del ámbito de la Sanidad Pública Valenciana

Awarded Contract award

Key facts

Awarded
Winner
MERCK SHARP & DOHME DE ESPAÑA, S.A.; AMGEN, S.A.; ALEXION PHARMA SPAIN, S.L; GLAXOSMITHKLINE, S.A.
Estimated value
€416,414,872
Buyer
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Where
Spain Comunitat Valenciana
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33622200 Antihypertensives 33610000 Medicinal products for the alimentary tract and metabolism 33621200 Antihaemorrhagics
7 more codes
33642000 Systemic hormonal preparations, excl. sex hormones 33651100 Antibacterials for systemic use 33651400 Antivirals for systemic use 33651500 Immune sera and immunoglobulins 33652100 Antineoplastic agents 33652300 Immunosuppressive agents 33673000 Medicinal products for obstructive airway diseases
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
281915-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Awarded
  2. Published

Description

Suministro de medicamentos de uso humano que contiene los principios activos Romiplostim, Carfilzomib y Etelcalcetida, con destino a los centros del ámbito de la Sanidad Pública Valenciana Lote 1 - Riociguat, Tedizolid, Ceftolozano / Tazobactam, Pembrolizumab, Letermovir, Doravirina; Lote 2 - Panitumumab, Romiplostim, Etelcalcetida, Carfilzomib, Sotorasib, Inebilizumab Panitumumab, Romiplostim, Etelcalcetida, Carfilzomib, Sotorasib, Inebilizumab; Lote 3 - Sebelipasa Alfa, Ravulizumab, Selumetinib; Lote 4 - Belimumab, Mepolizumab, Niraparib, Dostarlimab, Sotrovimab

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

6 open tenders right now

Recent awards

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Read before bidding
    • Estimated value: Set to €416,414,872
    • Award date: Awarded on March 3, 2026
    • Scope and criteria: The description was expanded. Re-read it before you bid.
    • Estimated value: Set to €416,414,872

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,447,367
10,065 open across Europe right now
Buyer track record on Aperlena
183 notices tracked · 109 awarded
€390,387,773 in awarded contracts

Never miss a tender like this

4,236 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language